°ÄÃÅÐÂÆÏ

µ±Ç°Î»Öãº ÍøÕ¾Ê×Ò³ > Ժϵ¿ìѶ > ÕýÎÄ

Ժϵ¿ìѶ
Ժϵ¿ìѶ
ÃÀ¹úÃÜЪ¸ù´óѧNeamati½ÌÊÚ·ÃÎÊҩѧԺ²¢×÷ѧÊõ±¨¸æ
À´Ô´£ºÒ©Ñ§Ôº    ÈÕÆÚ£º2025-05-27     ä¯ÀÀ´ÎÊý£º
¡¡¡¡5ÔÂ21ÈÕÉÏÎ磬¹ú¼ÊÖªÃûÒ©Îﻯѧ¼Ò¡¢ÃÀ¹úÃÜЪ¸ù´óѧҩѧԺ½ÌÊÚ¡¢Ò©ÎﻯѧȨÍþÆÚ¿¯¡¶Journal of Medicinal Chemistry¡·¸±Ö÷±àNouri Neamati½ÌÊÚÓ¦Ñû·ÃÎʰÄÃÅÐÂÆÏҩѧԺ¡£Neamati½ÌÊÚÎ§ÈÆÖ×Áö´úл°ÐÏòÖÎÁƵÄÇ°ÑØÑо¿£¬×÷ÁËÌâΪ¡°Oxidative Phosphorylation Inhibitors: Targeting the Vulnerabilities of Cancer Cell Metabolism¡±µÄѧÊõ±¨¸æ¡£Ò©Ñ§Ôºµ³Î¯Êé¼ÇÕÅÑåÃñ½ÌÊÚÖ÷³ÖÁ˴˴α¨¸æ»á¡£
¡¡¡¡±¨¸æÖУ¬Neamati½ÌÊÚÖ÷Òª½éÉÜÑõ»¯Á×Ëữ£¨OXPHOS£©ÒÖÖÆ×÷ΪÖÎÁÆÄ³Ð©ÒÀÀµÓÐÑõ´úлµÄ°©Ö¢µÄвßÂÔ¡£½áºÏÍŶӵÄ×îÐÂÑо¿³É¹û£¬ËûÉîÈë½éÉÜÁËͨ¹ý±íÐÍɸÑ¡£¬·¢ÏÖÁËÒ»¸ö³õʼ»¯ºÏÎï benzene-1,4-disulfonamide£¬¸Ã»¯ºÏÎïÔÚº¬°ëÈéÌÇÅàÑø»ùÖжÔϸ°û¾ßÓÐÑ¡ÔñÐÔ¶¾ÐÔ¡£Ëæºó£¬ËûÃÇ¿ªÕ¹ÁËϵͳµÄ½á¹¹ÓÅ»¯ºÍ¹¹Ð§¹ØÏµ£¨SAR£©Ñо¿¡£×îÖÕ£¬Ñо¿Õßɸѡ³ö»¯ºÏÎïDX3-121B£¬ÆäÔÚÄÉĦ¶ûŨ¶Èϼ´¿ÉÏÔÖøÒÖÖÆÏßÁ£Ì帴ºÏÎïIµÄ¹¦ÄÜÒÔ¼°ATPµÄ²úÉú£¬²¢ÔÚÌØ¶¨ÅàÑøÌõ¼þϱíÏÖ³öÏÔÖøÏ¸°û¶¾ÐÔ¡£´ËÍ⣬ÔÚСÊóÌåÄÚÄÍÊÜÐÔÁ¼ºÃ£¬²¢ÔÚPan02ͬԴÐÔÒÈÏÙ°©Ä£ÐÍÖÐÕ¹ÏÖ³öÏÔÖøµÄµ¥Ò©ÖÎÁÆÐ§¹û£¬ÎªÖ×Áö´úл°ÐÏòÖÎÁÆÌṩÁË˼·ºÍ²Î¿¼¡£
¡¡¡¡±¨¸æÏÖ³¡Æø·ÕÈÈÁÒ£¬Neamati½ÌÊÚÓëÔÚ³¡Ê¦ÉúÕ¹¿ªÁËÉîÈ뻥¶¯¡£Õë¶Ô¡°AIÔڹǼÜԾǨÉè¼ÆÖеÄÓ¦ÓÃÏÖ×´ÓëδÀ´Ç÷ÊÆ¡±¡¢¡°NAD+ÔÚÖ×ÁöÔ¤·ÀºÍÖÎÁÆÖеÄ×÷Óᱡ¢¡°ºÏ³É»¯Ñ§±³¾°µÄ¿ÆÑÐÈËÔ±ÈçºÎ·¢ÆðFirst-in-classÒ©ÎïÑо¿¡±ÒÔ¼°¡°ÈçºÎ¿´´ýFDA²»ÔÙÒªÇóÒ©Îï½øÐж¯ÎïÊÔÑéµÄ¿´·¨¡±µÈ¶à¸öÇ°ÑØ»°Ì⣬Neamati½ÌÊÚ½áºÏ×ÔÉí·á¸»µÄ¿ÆÑо­ÑéºÍʵ¼ÊÑо¿°¸Àý£¬¸ø³öÁ˾ßÓÐÀíÂÛÉî¶ÈÓëʵ¼ùÖ¸µ¼ÒâÒåµÄ¾«²Ê»Ø´ð£¬Ó®µÃÁËÕóÕóÕÆÉù¡£
¡¡¡¡±¨¸æ½áÊøºó£¬Neamati½ÌÊÚÓëʦÉúºÏÓ°ÁôÄî¡£ÕÅÑåÃñÊé¼ÇÔÚ×ܽáÖбíʾ£¬Õⳡ¾«²ÊµÄѧÊõ±¨¸æ£¬²»½öÈÃÎÒÃÇÁìÂÔµ½¹ú¼Ê¶¥¼âѧÕßÔÚÒ©ÎïÑз¢ÁìÓòµÄÉî¿Ì¶´¼û£¬¸üÒÔÆäÇ°ÑØµÄÑо¿Ë¼Â·ºÍÍ»ÆÆÐԳɹû£¬ÎªÔÚ³¡Ê¦Éú´ò¿ªÁËеÄѧÊõÊÓÒ°¡£±¨¸æÖÐǰհÐÔÑо¿Óë̽Ë÷£¬ÎªÎÒÃÇδÀ´µÄ¿ÆÑй¤×÷ÌṩÁ˱¦¹óµÄ½è¼ø£¬Ò²½«ÖúÁ¦Ò©Ñ§ÔºÔÚ´´ÐÂÒ©ÎïÑз¢·½ÃæµÄ¸ßÖÊÁ¿·¢Õ¹¡£Neamati½ÌÊÚÒ²±íʾ£¬´Ë´Î·ÃÎʶ԰ÄÃÅÐÂÆÏºÍҩѧԺÁôÏÂÁËÉî¿ÌµÄÓ¡Ïó£¬Ï£Íû°ÄÃÅÐÂÆÏҩѧԺԽÀ´Ô½ºÃ£¬Ò²ÆÚ´ýÒÔ±¾´Î½»Á÷ΪÆõ»ú£¬½øÒ»²½É°ÄÃÅÐÂÆÏÓëÃÜЪ¸ù´óѧµÄºÏ×÷½»Á÷¡£
  • ½»´óÖ÷Ò³
  • ѧ²¿ÐÅÏä
  • ˼ԴBBS
  • ͼÊé¹Ý
  • ˼ԴÓʼþ
  • ÐÅÏ¢ÃÅ»§
  • ½ÌʦÖ÷Ò³

µØÖ·£ºÉÂÎ÷Ê¡Î÷°²ÊÐÑãËþÎ÷·76ºÅ£¬Óʱࣺ710061

°æÈ¨ËùÓУº°ÄÃÅÐÂÆÏ

·ÃÎÊÁ¿£º

΢ÐÅÆ½Ì¨

°ÄÃÅÐÂÆÏµç×ÓÓÎÏ·Íø³©Íæ°ÄÃÅÐÂÆÏµç×ÓÓÎϷƽ̨¾¡ÏíÓéÀÖÊ¢Ñç